RH's Q4 Earnings Miss Exacerbates Leverage and Macro Concerns, Validating Cautionary Stance

What happened

RH reported a double miss in Q4 2025, with adjusted EPS of $1.53 falling short of the $2.22 consensus and revenue of $842.62 million missing the $873.32 million estimate. This underperformance occurs against a backdrop of high financial leverage, where the DeepValue report notes net debt/EBITDA at 8.6x and interest coverage of 1.6x, leaving minimal cushion for setbacks. The weak full-year forecast signals ongoing challenges in converting mid-single-digit revenue growth into stable earnings, as heavy capital expenditures on gallery expansions and macro-sensitive demand weigh on margins. Critical analysis reveals that this miss delays progress on key watch items like positive free cash flow and debt reduction, essential for upgrading from the 'WAIT' recommendation. Overall, the news underscores RH's precarious position as a leveraged, cyclical play without a clear margin of safety, aligning with prior concerns about execution and housing exposure.

Implication

The earnings shortfall directly undermines RH's ability to deleverage, making it harder to achieve the net debt/EBITDA reduction below 4x required for a more constructive view. With weak forecasts, the timeline for generating consistently positive free cash flow—a key watch item—extends, heightening refinancing and solvency risks. Investors must now scrutinize upcoming quarters for evidence that gallery investments and international expansion are yielding improved margins and occupancy leverage, not just revenue growth. This development amplifies the macro sensitivity noted in the report, as any downturn in luxury housing demand could further strain the balance sheet. Consequently, conservative capital should adhere to the 'WAIT' stance, avoiding exposure until clearer signs of financial stability and operational execution emerge.

Thesis delta

The Q4 miss reinforces the existing 'WAIT' thesis by demonstrating that RH's operational and financial vulnerabilities persist despite some revenue recovery. It does not provide the necessary evidence of sustained free cash flow or leverage improvement required to shift to a potential buy, and instead highlights increased risk from weak forecasts. Therefore, the thesis remains unchanged, with a heightened focus on monitoring for deterioration that could warrant a more negative stance.